Craft

Linical

Stock Price

¥373

2024-10-29

Market Capitalization

¥8.1 B

2024-10-29

Revenue

¥10.4 B

FY, 2025

Linical Summary

Company Summary

Overview
Linical is a contract research organization that focuses on oncology, immunology, respiratory and allergy, endocrinology, and other therapeutic areas. The company specializes in consulting, project management, clinical monitoring, clinical data management, biostatistics, medical writing, medical management, pharmacovigilance, pharma resourcing solutions, and early oncology development.
Type
Public
Status
Active
Founded
2005
HQ
Osaka, JP | view all locations
Website
https://www.linical.com/
Cybersecurity rating
Sectors

Key People

  • Carlos M. Hortelano

    Carlos M. Hortelano, Chief Scientific Officer Europe

    • Rafael Romero

      Rafael Romero, CEO, Linical Europe

      • Ángel Pérez

        Ángel Pérez, Associate Director, Clinical Operations Europe

        • María Agueda Del Cura

          María Agueda Del Cura, Director, Clinical Data Management Linical Europe

          LocationsView all

          22 locations detected

          • Osaka, Osaka HQ

            Japan

            1-chōme-19-23 Miyahara, Yodogawa-ku

          • Hudson, MA

            United States

            Cabot Rd

          • Rockville, MD

            United States

            2275 Research Blvd #700

          • San Diego, CA

            United States

            8880 Rio San Diego Dr #800

          • Stuart, FL

            United States

            789 SW Federal Hwy #100

          • NY

            United States

            68 3rd St, Brooklyn

          and 16 others

          Linical Financials

          Summary Financials

          Revenue (H1, 2026)
          ¥4.9B
          Gross profit (H1, 2026)
          ¥1.3B
          Net income (H1, 2026)
          (¥927.6M)
          Cash (H1, 2026)
          ¥5.4B
          EBIT (H1, 2026)
          (¥511.1M)
          Enterprise value
          $5.1B

          Footer menu